EU Finds Lundbeck Pay-For-Delay Deals Blocked Generics
By Megan Leonhardt ( July 25, 2012, 1:57 PM EDT) -- The European Commission accused Danish drugmaker H. Lundbeck A/S and others on Wednesday of violating EU antitrust rules by inking so-called pay-for-delay deals with generic competitors to keep cheaper versions of blockbuster antidepressant citalopram off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.